Treatment and surveillance for non-muscle-invasive bladder cancer in China: an evidence-based clinical practice guideline (2018 simplified version)_Chinese Journal of Evidence-Based Medicine

Authors：

 Urological Association, Chinese Research Hospital Association (CRHA); Urological Health Promotive Association, China International Exchange and Promotive Association for Medical and Health Care (CPAM); Evidence-Based Medicine Association, China International Exchange and Promotive Association for Medical and Health Care (CPAM); The Project Team for Minimally Invasive Plasma Kinetic System and Cloud Planning Solution, The National Key Research and Development Program of China

Corresponding?author：

Urological Association, Chinese Research Hospital Association (CRHA); Urological Health Promotive Association, China International Exchange and Promotive Association for Medical and Health Care (CPAM); Evidence-Based Medicine Association, China International Exchange and Promotive Association for Medical and Health Care (CPAM); The Project Team for Minimally Invasive Plasma Kinetic System and Cloud Planning Solution, The National Key Research and Development Program of China, Email: wangxinghuan1965@163.com; hedl@xjtu.edu.cn

Keywords：

Non-muscle-invasive bladder cancer; Transurethral resection of bladder tumor; Bacillus Calmette-Guérin; Treatment surveillance; Evidence-based clinical practice guideline

DOI：

10.7507/1672-2531.201812031

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： Urological Association, Chinese Research Hospital Association (CRHA); Urological Health Promotive Association, China International Exchange and Promotive Association for Medical and Health Care (CPAM); Evidence-Based Medicine Association, China International Exchange and Promotive Association for Medical and Health Care (CPAM); The Project Team for Minimally Invasive Plasma Kinetic System and Cloud Planning Solution, The National Key Research and Development Program of China. Treatment and surveillance for non-muscle-invasive bladder cancer in China: an evidence-based clinical practice guideline (2018 simplified version). Chinese Journal of Evidence-Based Medicine, 2018, 18(12): 1267-1272. doi: 10.7507/1672-2531.201812031 Copy

1.	靳英輝, 曾憲濤, 劉同族, 等. 非肌層浸潤性膀胱癌治療與監測循證臨床實踐指南研究方案. 中國研究型醫院, 2018, 5(3): 42-51.
2.	中國研究型醫院學會泌尿外科學專業委員會, 中國醫療保健國際交流促進會泌尿健康促進分會, 中國醫療保健國際交流促進會循證醫學分會, 等. 中國良性前列腺增生癥經尿道等離子雙極電切術治療指南 (2018 標準版). 中華醫學雜志, 2018, 98(20): 1549-1560.
3.	中國研究型醫院學會泌尿外科學專業委員會, 中國醫療保健國際交流促進會泌尿健康促進分會, 中國醫療保健國際交流促進會循證醫學分會, 等. 中國良性前列腺增生癥經尿道等離子雙極電切術治療指南 (2018 簡化版). 中國循證醫學雜志, 2018, 88(6): 543-546.
4.	Sobin DH, Witteking Ch, eds. TNM Classification of Malignant tumors, 6th ed. New York: Wiley-Liss, 2002.
5.	Sobin LH, Gospodariwicz M, Wittekind C, eds. TNM classification of malignant tumors. UICC International Union against cancer, 7th ed. New York: Wiley-Blackwell, 2009.
6.	Sauter G, Algaba F, Amin M, et al. Tumour of urinary system: non-invasive urothelial neoplasia. In Eble JN, Sauter G, Epstein JI, Sesterhenn, et al. WHO classification of classification of tumour of urinary system and male genital organs. Lyon: IARCC Press, 2004.
7.	Epstein JI, Amin MB, Reuter VR, et al. The World Health Organization/ International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol, 1998, 22: 1435-1448.
8.	Kurth KH, Denis L, Bouffioux C, et al. Factors affecting recurrence and progression in superficial bladder cancer. Eur J Cancer, 1995, 31A: 1840-1846.
9.	Parmar MKB, Freedman LS, Hargreave TB, et al. Prognostic factors for recurrence and follow-up policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer. J Urol, 1989, 142: 284-288.
10.	Witjes JA, Kiemenig La LM, Oosterhof GON, et al. Prognostic factors in superficial bladder cancer. Eur Urol, 1992, 21: 89-97.
11.	Allard P, Bernard P, Fradet Y, et al. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol, 1998, 81: 692-698.
12.	Fuji Y, Fukui I, Kihara K, et al. Significance of bladder neck involvement on progression in superficial bladder cancer. Eur Urol, 1998, 33: 464-468.

1. 靳英輝, 曾憲濤, 劉同族, 等. 非肌層浸潤性膀胱癌治療與監測循證臨床實踐指南研究方案. 中國研究型醫院, 2018, 5(3): 42-51.
2. 中國研究型醫院學會泌尿外科學專業委員會, 中國醫療保健國際交流促進會泌尿健康促進分會, 中國醫療保健國際交流促進會循證醫學分會, 等. 中國良性前列腺增生癥經尿道等離子雙極電切術治療指南 (2018 標準版). 中華醫學雜志, 2018, 98(20): 1549-1560.
3. 中國研究型醫院學會泌尿外科學專業委員會, 中國醫療保健國際交流促進會泌尿健康促進分會, 中國醫療保健國際交流促進會循證醫學分會, 等. 中國良性前列腺增生癥經尿道等離子雙極電切術治療指南 (2018 簡化版). 中國循證醫學雜志, 2018, 88(6): 543-546.
4. Sobin DH, Witteking Ch, eds. TNM Classification of Malignant tumors, 6th ed. New York: Wiley-Liss, 2002.
5. Sobin LH, Gospodariwicz M, Wittekind C, eds. TNM classification of malignant tumors. UICC International Union against cancer, 7th ed. New York: Wiley-Blackwell, 2009.
6. Sauter G, Algaba F, Amin M, et al. Tumour of urinary system: non-invasive urothelial neoplasia. In Eble JN, Sauter G, Epstein JI, Sesterhenn, et al. WHO classification of classification of tumour of urinary system and male genital organs. Lyon: IARCC Press, 2004.
7. Epstein JI, Amin MB, Reuter VR, et al. The World Health Organization/ International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol, 1998, 22: 1435-1448.
8. Kurth KH, Denis L, Bouffioux C, et al. Factors affecting recurrence and progression in superficial bladder cancer. Eur J Cancer, 1995, 31A: 1840-1846.
9. Parmar MKB, Freedman LS, Hargreave TB, et al. Prognostic factors for recurrence and follow-up policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer. J Urol, 1989, 142: 284-288.
10. Witjes JA, Kiemenig La LM, Oosterhof GON, et al. Prognostic factors in superficial bladder cancer. Eur Urol, 1992, 21: 89-97.
11. Allard P, Bernard P, Fradet Y, et al. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol, 1998, 81: 692-698.
12. Fuji Y, Fukui I, Kihara K, et al. Significance of bladder neck involvement on progression in superficial bladder cancer. Eur Urol, 1998, 33: 464-468.

Next Article
The interpretation of clinical practice guideline for abdominal aortic aneurysm of American Society for Vascular Surgery in 2018

Chinese Journal of Evidence-Based Medicine

Treatment and surveillance for non-muscle-invasive bladder cancer in China: an evidence-based clinical practice guideline (2018 simplified version)

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content